Published in J Pharm Sci on June 01, 1976
Binding of drugs by albumin and plasma protein. J Pharm Sci (1977) 1.31
Effect of pH on the binding of theophylline to serum proteins. Am Rev Respir Dis (1979) 1.18
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg (1985) 1.01
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics (1997) 0.94
Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm (1986) 0.94
Tumor concentration of platinum in patients with head and neck cancer. Otolaryngol Head Neck Surg (1983) 0.93
Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. Clin Pharm (1984) 0.92
Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther (1981) 0.87
Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II). Cancer Treat Rep (1980) 0.87
Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep (1978) 0.87
Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma. J Chromatogr (1980) 0.86
High-pressure liquid chromatographic analysis of aniline and its metabolites. J Chromatogr (1977) 0.84
Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein. J Pharm Pharmacol (1988) 0.83
Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther (1999) 0.83
Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin. J Pharm Sci (1976) 0.83
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
Rational design and evaluation of improved o-phthalaldehyde-like fluorogenic reagents. Anal Biochem (1985) 0.83
Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193). Cancer Res (1985) 0.83
Enzymatic oxidation of diphenylmethylphosphine and 3-dimethylaminopropyldiphenylphosphine by rat liver microsomes. Biochem Pharmacol (1972) 0.82
Analysis of hydrophobic amine antimalarials in biological fluids with the plastic ion-selective electrode. J Pharm Sci (1979) 0.81
A study of the solubility of amphotericin B in nonaqueous solvent systems. J Parenter Sci Technol (1989) 0.80
Detection of arylhydroxylamines as intermediates in the metabolic reduction of nitro compounds. Experientia (1975) 0.80
Cephalosporins for surgical prophylaxis: computer projections of intraoperative availability. South Med J (1985) 0.80
Clearance of serum cortisol in suckled and nonsuckled postpartum beef cows. J Anim Sci (1981) 0.80
Plasma levels and urinary excretion of methyl-GAG following iv infusion in man. Cancer Treat Rep (1981) 0.79
Intraoperative ceforanide pharmacokinetics and protein binding. Antimicrob Agents Chemother (1985) 0.79
Factors affecting the stability of fluorescent isoindoles derived from reaction of o-phthalaldehyde and hydroxyalkylthiols with primary amines. Anal Biochem (1983) 0.78
Oxidation of phenylhydroxylamine in aqueous solution: a model for study of the carcinogenic effect of primary aromatic amines. Proc Natl Acad Sci U S A (1981) 0.78
Analysis of fluorescence quenching data by the method of Levine. Clin Chem (1980) 0.78
Clinical analysis of tamoxifen, an anti-neoplastic agent, in plasma. Clin Chem (1978) 0.78
Metabolic conversion of fluorenone oxime to phenanthridinone by hepatic enzymes. J Pharm Sci (1979) 0.78
Influence of tamoxifen and its N-desmethyl and 4-hydroxy metabolites on rat liver microsomal enzymes. Biochem Pharmacol (1984) 0.77
Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobamate: a comparative study in acute low back pain. Br J Clin Pract (1987) 0.77
Post-column reaction detector for platinum(II) antineoplastic agents. Anal Chem (1984) 0.76
The effect of amine structure on complexation with lasalocid in model membrane systems. I. Identification of charged complexes in lipid bilayer membranes. Biochim Biophys Acta (1982) 0.76
Fluorogenic derivatization of peptides with naphthalene-2,3-dicarboxaldehyde/cyanide: optimization of yield and application in the determination of leucine-enkephalin spiked human plasma samples. J Pharm Biomed Anal (1990) 0.76
Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate. J Chromatogr (1979) 0.76
Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes. J Chromatogr (1983) 0.76
Evaluation of the performance of controlled release dosage forms of ticlopidine using in vitro intestinal permeability and computer simulations. J Drug Target (1994) 0.75
Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects. J Clin Pharmacol (1980) 0.75
The effect of amine structure on complexation with lasalocid in model membrane systems. II. Ionophore selectivity for amines in lipid bilayers and at oil/water interfaces. Biochim Biophys Acta (1982) 0.75
Loss of hydrophobic amine from solution by adsorption onto container surfaces. J Pharm Sci (1979) 0.75
Analysis of riboxamide in plasma by high-performance liquid chromatography using automated column switching. J Chromatogr (1983) 0.75
Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. J Pharm Pharmacol (1991) 0.75
A new method for the determination of the site binding constant of each species of a partially ionized drug. Acta Pharm Suec (1980) 0.75
Analysis of riboxamide in urine by high-performance liquid chromatography. J Chromatogr (1984) 0.75
Effect of a perfluorochemical emulsion on prednisolone binding by human albumin. Biochem Pharmacol (1986) 0.75
Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute. Arch Int Pharmacodyn Ther (1985) 0.75
Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin. Arch Int Pharmacodyn Ther (1990) 0.75
Analytical challenges to the pharmaceutical industry in developing products of biotechnology. J Pharm Biomed Anal (1989) 0.75
High-performance liquid chromatographic assay for methylglyoxal bis(guanylhydrazone) (methyl GAG) in plasma and urine. J Chromatogr (1980) 0.75
High-performance liquid chromatography of platinum complexes on solvent generated anion exchangers. III. Application to the analysis of cisplatin in urine using automated column switching. J Chromatogr (1982) 0.75
Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin. Arch Int Pharmacodyn Ther (1987) 0.75
Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination. Drug Metab Rev (1991) 0.75
Interaction of nitromethane with reduced hepatic microsomal cytochrome P-450. Biochem Pharmacol (1977) 0.75
Design and synthesis of a theophylline bonded-phase column for HPLC--application to separation of aromatic carboxylic acids. J Pharm Biomed Anal (1987) 0.75
Studies on the distribution of dianhydrogalactitol into the central nervous system of the rat. Cancer Treat Rep (1978) 0.75
Effects of a perfluorochemical blood substitute on diazepam binding by human albumin. J Pharm Pharmacol (1988) 0.75
Factors affecting the retention of quaternary ammonium ions in reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal (1983) 0.75
High-performance liquid chromatographic analysis of dianhydrogalactitol in plasma by derivatization with sodium diethyldithiocarbamate. J Chromatogr (1977) 0.75
High-performance liquid chromatographic analysis of miconazole in plasma. J Chromatogr (1982) 0.75
Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II). Clin Chem (1978) 0.75
Cation exchange contribution to the retention of specific quaternary ammonium compounds in reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal (1983) 0.75
The effect of protein concentration on the binding of sulfamethoxypyridazine by human and bovine serum albumin. Arch Int Pharmacodyn Ther (1980) 0.75
Furosemide binding by human albumin: comparison of two methods of fluorescence quenching analysis. J Pharm Sci (1983) 0.75
Analysis of nitrosamines in aqueous and biological fluids based on measurement of photochemically liberated nitrite. J Pharm Sci (1979) 0.75
High-performance liquid chromatography of cisplatin. J Pharm Sci (1983) 0.75
Suitability of DTAF as a fluorescent labelling reagent for direct analysis of primary and secondary amines--spectral and chemical reactivity considerations. J Pharm Biomed Anal (1989) 0.75
A differential pulse polarographic assay for O-methylation of catechols by catechol-O-methyltransferase. Anal Biochem (1976) 0.75
Direct potentiometric and titrimetric determination of methadone in urine with plastic electrodes selectiive for hydrophobic cations. Anal Chem (1978) 0.75
Metabolic rearrangement of fluorenone oxime by rat liver homogenates. Biochem Pharmacol (1978) 0.75
Liquid chromatographic determination of cyclophosphamide enantiomers in plasma by precolumn chiral derivatization. Anal Chem (1989) 0.75
Kinetics of digoxin stability in aqueous solution. J Pharm Sci (1978) 0.75
Aspects of the stability of isoindoles derived from the reaction of o-phthalaldehyde-ethanethiol with primary amino compounds. J Pharm Biomed Anal (1986) 0.75
Monitoring the reactions of cisplatin with nucleotides and methionine by reversed-phase high-performance liquid chromatography using cationic and anionic pairing ions. Anal Biochem (1983) 0.75
A contact detection system for identifying individual animals in groups. Physiol Behav (1972) 0.75
Biotransformation of azapetine to oxazapetine in rat and rabbit liver fractions. Drug Metab Dispos (1979) 0.75
Gas chromatographic analysis of acetophenone oxime and its metabolites. J Chromatogr (1977) 0.75
Scatchard plot analysis of ligand--erythrocyte interactions. J Pharm Sci (1978) 0.75
Assessment of cisplatin reactivity with peptides and proteins using reverse-phase high-performance liquid chromatography and flameless atomic absorption spectroscopy. Anal Biochem (1982) 0.75
Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma. Clin Chem (1977) 0.75
Limitations of fluorescence quenching data analysis in dantrolene binding by human albumin. Pharm Acta Helv (1987) 0.75
A preliminary Pharmacokinetic study of dianhydrogalactitol (NSC-132313) disposition in the dog. J Natl Cancer Inst (1977) 0.75
Loss of propranolol during ultrafiltration in plasma protein binding studies. Res Commun Chem Pathol Pharmacol (1986) 0.75
The effect of the anion on the absorption of tetracycline from the rat stomach. J Pharm Pharmacol (1970) 0.75
Effect of impaired renal function on tamoxifen. J Surg Oncol (1984) 0.75
Dynamic dialysis in drug-erythrocyte interactions. J Pharm Sci (1979) 0.75
Fluorescence stability of human albumin solutions. J Pharm Sci (1982) 0.75
Laboratory decontamination and destruction of carcinogens in laboratory wastes: some aromatic amines and 4-nitrobiphenyl. IARC Sci Publ (1985) 0.75
Analysis by liquid chromatography of desipramine in aqueous solutions and plasma application of dichlorotriazinylaminofluorescein (DTAF) as a pre-column fluorescent derivatising agent for selected secondary amines. J Pharm Biomed Anal (1988) 0.75
Trace analysis for cis-platinum anti-cancer drugs via LCEC. J Chromatogr Sci (1983) 0.75
Avascular necrosis of the proximal humeral epiphysis after physeal fracture. A case report. J Bone Joint Surg Am (1997) 0.75
Unexpectedly rapid esterification of nitrite applied to the determination of nitrite in water. Anal Chem (1978) 0.75
High-performance liquid chromatographic analysis of emetine after oxidative activation to a fluorescent product. J Chromatogr (1979) 0.75
The application of chemical derivatization to clinical drug analysis. Xenobiotica (1987) 0.75
Determination of aniline and its degradation products by high-performance liquid chromatography. IARC Sci Publ (1981) 0.75
Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma. Clin Chem (1976) 0.75